Routine Blood Tests May Predict Long-Term Dementia Risk
Routine blood screening tests and advanced genetic markers are offering doctors new ways to estimate long-term dementia risks and track cognitive impairment.
Health, medicine, biotech and the science of living longer and better.
Routine blood screening tests and advanced genetic markers are offering doctors new ways to estimate long-term dementia risks and track cognitive impairment.
Researchers at Jawaharlal Nehru University have targeted the human protein p38-MAPK to weaken both malaria and kala-azar parasites in laboratory cells, offering a potential…
During a one-year period at a tertiary care center in Eastern India, seven patients with post-procedural wound infections were identified with culture-confirmed M.
Researchers at Kyoto University discovered that administering olive oil before carbohydrates blunts early blood sugar spikes in mice by slowing gastric emptying and triggering a…
Plague has returned to global headlines following a researcher’s fatal pneumonia in Siberia, prompting World Health Organization scrutiny.
Universal germline genetic testing across nearly 40,000 cancer patients at Memorial Sloan Kettering Cancer Center revealed that standard age-based screening cutoffs miss a…
More than one in 10 people across the European Union could not afford regular leisure activities in 2025, according to Eurostat data released in October 2026.
Cystic echinococcosis imposes a severe burden across Ethiopia through livestock economic losses and diminished patient quality of life.
Tarlatamab, a bispecific T-cell engager approved for relapsed extensive-stage small cell lung cancer, has shown significant clinical activity alongside notable toxicity rates.
A 104-week clinical trial published in the British Journal of Nutrition reveals that non-nutritive sweetened soft drinks perform equivalently to water for long-term weight…
UK Research and Innovation has launched an up-to-£80 million Dementia Challenge to test nine medical technologies within the NHS.
Researchers at Stanford Medicine and the VA Palo Alto Health Care System have developed a non-invasive urine test called uRARE-seq that measures cell-free RNA to diagnose bladder…
We use cookies to run this site, measure traffic and — with your consent — to personalize ads. See our Cookie Policy.